kupdf.net_manual-practico-medicina-estetica

Toxina botulínica
2. Hankins CL, Strimling R, Rogers GS. Botulinum
A toxin fo r glabelar wrinkles. Dose and response.
Dermatol Surg. 1998; 24 (11): 1181-1183.
3. Tsui JK, Wong NLM, Wong E, Calne DB.
Production o f circulating antibodies to botulinum
A toxin in patients receiving repeated injections fo r
dystonia. Ann Neurol 1988; 23:181.
4. Santos Jl, Swensen P, Glasgow LA. Potentiation
ofClostridium botulinum toxin by aminoglycosides
antibiotics: clinical and laboratory observations.
Pediatrics 1981; 68: 50-54.
5. Simpson LL. The interaction between
aminoquinolines and presynaptically acting
neurotoxins. J Pharmacol Exp Ther 1982; 222: 43-
48.
6. PopoffM R, M arvaud C, Raffestin S. Mechanism
o f action and therapeutic uses o f botulinum and
tetanus neurotoxins. Ann Pharm Fr. 2001; 59 (3):
176-190.
7. Pearce LB, First ER, MacCallum RD, Grupta A.
Pharmacologic characterization o f botulinum toxin
fo r basic Science and medicine. Toxicon. 1997; 35
(9): 1373-1412.
8. Boni K, Kreyden OP, Burg G. Revival o f the use
o f botulinum toxin: application in dermatology.
Dermatology. 2000; 200 (4): 287-291.
9. Schantz EJ, Johnnson EA. Dose standardization
o f botulinum toxin. Lancet 1989; 335: 421
10. Me Lellan K, Das RE, Ekong TA. Therapeutic
boyulinum type A toxin: factors affecting poteney.
Toxicon 1996; 34: 975-985
11. Carucci JA, Zweibel SM. Botulinum A exotoxin
fo r rejuvenation ofth e upper third o f the face. Facial
Plast Surg. 2001; 17 (1): 11-20.
12. Naver H, Aquilonius SM. The treatment o f focal
hyperhidrosis with botulinum toxin. Eur J Neurol
1997; 4 (2): S75-S79.
93